Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung Cancer
Clinical trial NCT00182806 · COMPLETED
Trial details
- NCT number
- NCT00182806
- Sponsor
- Roswell Park Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2007-09-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.